It has been reported that curcumin potentiates the antitumor activity of paclitaxel in breast cancer by influencing the expression of NF-κB-regulated gene products [34]; for this reason we performed DNA binding assay on tumors of control and curcumin-treated mice. The gene discussed is NFKB1; the disease is breast carcinoma.